Assessment of polypharmacy, potentially inappropriate medications, and drug-drug interactions in older patients with cancer

被引:2
作者
Albayrak, Aslinur [1 ]
Erbay, Bahar [2 ]
Kayikcioglu, Erkan [3 ]
机构
[1] Suleyman Demirel Univ, Fac Pharm, Dept Clin Pharm, Isparta, Turkiye
[2] Suleyman Demirel Univ, Fac Pharm, Isparta, Turkiye
[3] Suleyman Demirel Univ, Fac Med, Dept Med Oncol, Isparta, Turkiye
关键词
Cancer; drug interactions; elderly; polypharmacy; potentially inappropriate medications; ELDERLY-PATIENTS; ADULTS; PEOPLE; IMPACT;
D O I
10.1177/10781552241255140
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: This study aimed to determine polypharmacy, potentially inappropriate medications, and potential drug-drug interactions in elderly patients hospitalized in the oncology services of a university hospital in Turkey. Methods: This retrospective cross-sectional study was conducted between September 2021 and September 2022 on cancer patients over 65 years old hospitalized at Suleyman Demirel University Medical Faculty Hospital in Isparta, Turkey. Potentially inappropriate medications were defined according to the 2023 Beers Criteria of the American Geriatrics Society. Potential drug-drug interactions were determined with Medscape (R) drug interaction checker. Results: The median (min-max) of drugs used by the patients was 6 (2-15). Most of the patients (74.3%) had polypharmacy. Approximately half of the patients (51.4%) had potentially inappropriate medications. The most commonly used potentially inappropriate medications were diuretics (22.1%), metoclopramide (11.4%), antidepressant drugs (7.9%), and opioids (6.4%). The presence of comorbidities, mental, behavioral, and neurodevelopmental disorders, circulatory system diseases, and respiratory system diseases were found to be statistically significantly higher in the group with potentially inappropriate medication than in the group without potentially inappropriate medication (p < 0.05). In total, 98 patients (70%) had at least one potential drug-drug interaction. Potential drug-drug interactions were minor in 33.3%, major in 57.5%, serious in 7.74%, and contraindicated in 0.22% Conclusion: According to our study, polypharmacy, potentially inappropriate medications, and potential drug-drug interactions were high in elderly cancer patients. It is important to determine potential drug-drug interactions and potentially inappropriate medications in cancer patients by a multidisciplinary team, including the clinical pharmacist, to prevent possible negative consequences.
引用
收藏
页码:693 / 699
页数:7
相关论文
共 29 条
[1]   Comparison of different decision support software programs in perspective of potential drug-drug interactions in the oncology clinic [J].
Bektay, Muhammed Yunus ;
Seker, Zehra ;
Eke, Hatice Kubra ;
Turk, Haci Mehmet ;
Izzettin, Fikret Vehbi .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (05) :1178-1186
[2]   Prevalence of potential drug-drug interactions in breast cancer patients and determination of their risk factors [J].
Bibi, Rashida ;
Azhar, Saira ;
Iqbal, Ayesha ;
Jabeen, Hajera ;
Kalsoom, Umm-e ;
Iqbal, Muhammad M. ;
Nazeer, Maria .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) :1616-1622
[3]   Drug-drug interactions in oncology: Why are they important and can they be minimized? [J].
Blower, P ;
de Wit, R ;
Goodin, S ;
Aapro, M .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 55 (02) :117-142
[4]   Systematic Review and Meta-Analysis on the Associations of Polypharmacy and Potentially Inappropriate Medication With Adverse Outcomes in Older Cancer Patients [J].
Chen, Li-Ju ;
Trares, Kira ;
Laetsch, Dana Clarissa ;
Nguyen, Thi Ngoc Mai ;
Brenner, Hermann ;
Schoettker, Ben .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2021, 76 (06) :1044-1052
[5]   Association of pre-operative medication use with post-surgery mortality and morbidity in oncology patients receiving comprehensive geriatric assessment [J].
Choi, Kyung Suk ;
Jeong, Young Mi ;
Lee, Eunsook ;
Kim, Kwang Ill ;
Yee, Jeong ;
Lee, Byung Koo ;
Chung, Jee Eun ;
Rhie, Sandy Jeong ;
Gwak, Hye Sun .
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 30 (10) :1177-1185
[6]   MASCC antiemetics in advanced cancer updated guideline [J].
Davis, Mellar ;
Hui, David ;
Davies, Andrew ;
Ripamonti, Carla ;
Capela, Andreia ;
DeFeo, Giulia ;
Del Fabbro, Egidio ;
Bruera, Eduardo .
SUPPORTIVE CARE IN CANCER, 2021, 29 (12) :8097-8107
[7]   Polypharmacy: A general review of definitions, descriptions and determinants [J].
Guillot, Jordan ;
Maumus-Robert, Sandy ;
Bezin, Julien .
THERAPIE, 2020, 75 (05) :407-416
[8]   Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay [J].
Hanlon, Joseph T. ;
Pieper, Carl F. ;
Hajjar, Emily R. ;
Sloane, Richard J. ;
Lindblad, Catherine I. ;
Ruby, Christine M. ;
Schmader, Kenneth E. .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2006, 61 (05) :511-515
[9]  
Hutchison LC., 2007, J PHARM PRACT, V20, P4, DOI [DOI 10.1177/0897190007304657, 10.1177/0897190007304657]
[10]   Polypharmacy in elderly patients with cancer: clinical implications and management [J].
Lees, Judith ;
Chan, Alexandre .
LANCET ONCOLOGY, 2011, 12 (13) :1249-1257